These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 12181777)
1. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Liede A; Malik IA; Aziz Z; Rios Pd Pde L; Kwan E; Narod SA Am J Hum Genet; 2002 Sep; 71(3):595-606. PubMed ID: 12181777 [TBL] [Abstract][Full Text] [Related]
2. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153 [TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017 [TBL] [Abstract][Full Text] [Related]
5. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767 [TBL] [Abstract][Full Text] [Related]
6. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791 [TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
9. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region. Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Meindl A; Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209 [TBL] [Abstract][Full Text] [Related]
11. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
12. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. Verhoog LC; van den Ouweland AM; Berns E; van Veghel-Plandsoen MM; van Staveren IL; Wagner A; Bartels CC; Tilanus-Linthorst MM; Devilee P; Seynaeve C; Halley DJ; Niermeijer MF; Klijn JG; Meijers-Heijboer H Eur J Cancer; 2001 Nov; 37(16):2082-90. PubMed ID: 11597388 [TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. Vaidyanathan K; Lakhotia S; Ravishankar HM; Tabassum U; Mukherjee G; Somasundaram K J Biosci; 2009 Sep; 34(3):415-22. PubMed ID: 19805903 [TBL] [Abstract][Full Text] [Related]
14. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558 [TBL] [Abstract][Full Text] [Related]
15. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. Chen S; Iversen ES; Friebel T; Finkelstein D; Weber BL; Eisen A; Peterson LE; Schildkraut JM; Isaacs C; Peshkin BN; Corio C; Leondaridis L; Tomlinson G; Dutson D; Kerber R; Amos CI; Strong LC; Berry DA; Euhus DM; Parmigiani G J Clin Oncol; 2006 Feb; 24(6):863-71. PubMed ID: 16484695 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. Shih HA; Couch FJ; Nathanson KL; Blackwood MA; Rebbeck TR; Armstrong KA; Calzone K; Stopfer J; Seal S; Stratton MR; Weber BL J Clin Oncol; 2002 Feb; 20(4):994-9. PubMed ID: 11844822 [TBL] [Abstract][Full Text] [Related]
17. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866 [TBL] [Abstract][Full Text] [Related]
18. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Anglian Breast Cancer Study Group Br J Cancer; 2000 Nov; 83(10):1301-8. PubMed ID: 11044354 [TBL] [Abstract][Full Text] [Related]
20. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]